<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>2000 Archives - ICRG - International Center for Responsible Gaming</title>
	<atom:link href="https://www.icrg.org/tag/2000/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description></description>
	<lastBuildDate>Sat, 16 Mar 2024 00:40:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>
	<item>
		<title>“Pharmacological Priming of Gambling-Related Cognitions by Amphetamine”</title>
		<link>https://www.icrg.org/funded-research/pharmacological-priming-of-gambling-related-cognitions-by-amphetamine/</link>
		
		<dc:creator><![CDATA[icrg_admin]]></dc:creator>
		<pubDate>Wed, 07 Dec 2022 06:44:25 +0000</pubDate>
				<category><![CDATA[Project Grants]]></category>
		<category><![CDATA[2000]]></category>
		<guid isPermaLink="false">https://www.icrg.org/blog/funded-research/pharmacological-priming-of-gambling-related-cognitions-by-amphetamine/</guid>

					<description><![CDATA[<p id="">Principal Investigator: Martin Zack, Ph.D., Centre for Addiction and Mental Health<br />Awarded $75,042 in 2000</p>
<p id="">Aim: Explore the role played by neurochemical activation in the development of gambling addiction.</p>
<p>‍</p>
<p>The post <a href="https://www.icrg.org/funded-research/pharmacological-priming-of-gambling-related-cognitions-by-amphetamine/">“Pharmacological Priming of Gambling-Related Cognitions by Amphetamine”</a> appeared first on <a href="https://www.icrg.org">ICRG - International Center for Responsible Gaming</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p id="">Principal Investigator: Martin Zack, Ph.D., Centre for Addiction and Mental Health<br />Awarded $75,042 in 2000</p>
<p id="">Aim: Explore the role played by neurochemical activation in the development of gambling addiction.</p>
<p>‍</p>
<p id="">Zack, M. &amp; Poulos, C.X. (2004). Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. <em id="">Neuropsychopharmacology, 29</em>, 195-207.</p>
<p>‍</p>
<p>The post <a href="https://www.icrg.org/funded-research/pharmacological-priming-of-gambling-related-cognitions-by-amphetamine/">“Pharmacological Priming of Gambling-Related Cognitions by Amphetamine”</a> appeared first on <a href="https://www.icrg.org">ICRG - International Center for Responsible Gaming</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>“Naltrexone and Citalopram Treatment of Pathological Gambling and Co-Morbid Alcohol Abuse or Dependence”</title>
		<link>https://www.icrg.org/funded-research/naltrexone-and-citalopram-treatment-of-pathological-gambling-and-co-morbid-alcohol-abuse-or-dependence/</link>
		
		<dc:creator><![CDATA[icrg_admin]]></dc:creator>
		<pubDate>Wed, 07 Dec 2022 06:44:01 +0000</pubDate>
				<category><![CDATA[Project Grants]]></category>
		<category><![CDATA[2000]]></category>
		<guid isPermaLink="false">https://www.icrg.org/blog/funded-research/naltrexone-and-citalopram-treatment-of-pathological-gambling-and-co-morbid-alcohol-abuse-or-dependence/</guid>

					<description><![CDATA[<p id="">Principal Investigator: Marc N. Potenza, MD, Ph.D., Yale School of Medicine<br />Awarded $172,500 in 2000</p>
<p id="">Aim: Test the short-term tolerability and efficacy of the antidepressant citalopram, naltrexone (a drug used to blunt cravings for alcohol) and a citalopram/naltrexone combination pharmacotherapy in the treatment of dually diagnosed patients with pathological gambling and alcohol abuse or dependence.</p>
<p>‍</p>
<p>The post <a href="https://www.icrg.org/funded-research/naltrexone-and-citalopram-treatment-of-pathological-gambling-and-co-morbid-alcohol-abuse-or-dependence/">“Naltrexone and Citalopram Treatment of Pathological Gambling and Co-Morbid Alcohol Abuse or Dependence”</a> appeared first on <a href="https://www.icrg.org">ICRG - International Center for Responsible Gaming</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p id="">Principal Investigator: Marc N. Potenza, MD, Ph.D., Yale School of Medicine<br />Awarded $172,500 in 2000</p>
<p id="">Aim: Test the short-term tolerability and efficacy of the antidepressant citalopram, naltrexone (a drug used to blunt cravings for alcohol) and a citalopram/naltrexone combination pharmacotherapy in the treatment of dually diagnosed patients with pathological gambling and alcohol abuse or dependence.</p>
<p>‍</p>
<p id="">Potenza, M.N. (2001). The neurobiology of pathological gambling. <em id="">Seminars in Clinical Neuropsychiatry, 6</em>, 217-226.</p>
<p id="">Potenza, M.N. (2001). Pathological gambling: A present problem from the past. <em id="">Psychiatric Times</em> (online exclusive).</p>
<p id="">Potenza, M.N. (2002). A perspective on future directions in the prevention, treatment, and research of pathological gambling. <em id="">Psychiatric Annals, 32</em>, 203-207.</p>
<p id="">Potenza, M.N. (2003). Pathological gambling and impulse control disorders. In J. Soares &amp; S. Gershon (Eds.), <em id="">Medical Handbook of Psychiatry</em>, pp. 683-700.</p>
<p id="">Potenza, M. N. (2005). Advancing Treatment Strategies for Pathological Gambling.<br /><em id="">Journal of Gambling Studies, 21</em>(1), 91-98.</p>
<p id="">Potenza, M.N. &amp; Charney, D.S. (2001). Pathological gambling: A current perspective. <em id="">Seminars in Clinical Neuropsychiatry, 6</em>, 153-154.</p>
<p id="">Potenza, M.N., Fiellin, D. A., Heninger, G.R., Rounsaville, B.J., &amp; Mazure, C.M. (2002). Gambling: An addictive behavior with health and primary care implications. <em id="">Journal of General Internal Medicine, 17,</em> 721-32.</p>
<p id="">Potenza, M.N. &amp; Hollander, E. (2002). Pathological gambling and impulse control disorders. In C. Nemeroff, J. Coyle, D. Charney, &amp; K. Davis (Eds.), <em id="">Neuropsychopharmacology: The 5th Generation of Progress.</em> Baltimore, MD: Lippincott, Williams and Wilkens.</p>
<p id="">Potenza, M.N., Kosten, T.R., &amp; Rounsaville, B.J. (2001). Pathological gambling. <em id="">Journal of the American Medical Association, 286</em>, 141-144.</p>
<p id="">Potenza, M.N., Leung, H.C., Blumberg, H.P., Peterson, B.S., Fulbright, R.K., Lacadie, C.M., et al. (2003). An fMRI Stroop study of ventromedial prefrontal cortical function in pathological gamblers. <em id="">American Journal of Psychiatry, 160</em>, 1990-1994.</p>
<p id="">Potenza, M.N., Steinberg, M.A., Skudlarski, P., Fulbright, R.K., Lacadie, C.M., Wilber, M.K., et al. (2003). An fMRI study of gambling urges in pathological gamblers. <em id="">Archives of General Psychiatry, 60</em>(8), 828-836.</p>
<p id="">Potenza, M.N. &amp; Wilber, M.K. (2001). Neuroimaging studies of pathological gambling and substance dependence. <em id="">Psychiatric Times, 18</em>(10): 58-64.</p>
<p id="">Potenza, M.N. &amp; Winters, K.C. (2003). The neurobiology of pathological gambling: Translating research findings into clinical advances. <em id="">Journal of Gambling Studies, 19</em>, 7-10.</p>
<p id="">Chambers R. A., &amp; Potenza, M.N., (2003). Impulse control disorders. In M.J. Aminoff &amp; R.B. Daroff (Eds.), <em id="">Encyclopedia of the Neurological Sciences</em> (Vol. 2). San Diego, CA: &nbsp;Academic Press.</p>
<p id="">Chambers, R. A. &amp; Potenza, M.N., (2003). Neurodevelopment, impulsivity and adolescent gambling. <em id="">Journal of Gambling Studies, 19</em>, 53-84.</p>
<p id="">Chambers, R. A., Taylor, J.R. &amp; Potenza, M.N. (2003). Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability. <em id="">American Journal of Psychiatry, 160</em>, 1041-1052.</p>
<p id="">Grant, J.E., Kim, S.W., &amp; Potenza, M.N. (2003). Advances in the pharmacological treatment of pathological gambling. <em id="">Journal of Gambling Studies, 19</em>, 85-109.</p>
<p id="">Grant, J. E., Kim, S.W., Potenza, M.N., Blanco, C., Ibanez, A., Stevens, L., et al. (2003). Paroxetine treatment of pathological gambling: A multi-centre randomized controlled trial. <em id="">International Clinical Psychopharmacology, 18,</em> 243-249.</p>
<p id="">Grant, J.E., &amp; Potenza, M.N. (Eds). (2004). <em id="">Pathological gambling: A clinical guide to treatment. </em>Washington, DC: &nbsp;American Psychiatric Press, Inc.</p>
<p id="">Shah, K.R., Eisen, S.A., Xian, H., Potenza, M.N. (2005). Genetic studies of pathological gambling: A review of methodology and analyses of data from the Vietnam Era Twin (VET) Registry. <em id="">Journal of Gambling Studies, 21</em>(2), 179-203.</p>
<p>‍</p>
<p>The post <a href="https://www.icrg.org/funded-research/naltrexone-and-citalopram-treatment-of-pathological-gambling-and-co-morbid-alcohol-abuse-or-dependence/">“Naltrexone and Citalopram Treatment of Pathological Gambling and Co-Morbid Alcohol Abuse or Dependence”</a> appeared first on <a href="https://www.icrg.org">ICRG - International Center for Responsible Gaming</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>“A Family-Genetic Study of Pathological Gambling”</title>
		<link>https://www.icrg.org/funded-research/a-family-genetic-study-of-pathological-gambling/</link>
		
		<dc:creator><![CDATA[icrg_admin]]></dc:creator>
		<pubDate>Wed, 07 Dec 2022 06:43:33 +0000</pubDate>
				<category><![CDATA[Project Grants]]></category>
		<category><![CDATA[2000]]></category>
		<guid isPermaLink="false">https://www.icrg.org/blog/funded-research/a-family-genetic-study-of-pathological-gambling/</guid>

					<description><![CDATA[<p id="">Principal Investigator: Donald W. Black, MD, University of Iowa<br />Awarded $169,929 in 2000</p>
<p id="">Aim: Understand the role that family history of gambling disorder plays in the development of pathological gambling. The investigator received a major grant from the National Institutes of Health in 2005 to continue the research.</p>
<p>‍</p>
<p>The post <a href="https://www.icrg.org/funded-research/a-family-genetic-study-of-pathological-gambling/">“A Family-Genetic Study of Pathological Gambling”</a> appeared first on <a href="https://www.icrg.org">ICRG - International Center for Responsible Gaming</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p id="">Principal Investigator: Donald W. Black, MD, University of Iowa<br />Awarded $169,929 in 2000</p>
<p id="">Aim: Understand the role that family history of gambling disorder plays in the development of pathological gambling. The investigator received a major grant from the National Institutes of Health in 2005 to continue the research.</p>
<p>‍</p>
<p id="">Black, D.W., &amp; Monahan, P.O., Temkit, M., &amp; Shaw, M. (2006). A family study of pathological gambling. <em id="">Psychiatry Research, 141</em>(3), 295-303.</p>
<p id="">Black, D.W., Moyer, T., &amp; Schlosser, S. (2003). Quality of life and family history in pathological gambling. <em id="">Journal of Nervous &amp; Mental Disease, 191</em>, 124-126.</p>
<p id="">Shaw, M.C., Forbush, K.T., Schlinder, J., Rosenman, E., &amp; Black, D.W. (2007). The effect of pathological gambling on families, marriages, and children. <em id="">CNS Spectrum, 12</em>(8), 615-622.</p>
<p>‍</p>
<p>The post <a href="https://www.icrg.org/funded-research/a-family-genetic-study-of-pathological-gambling/">“A Family-Genetic Study of Pathological Gambling”</a> appeared first on <a href="https://www.icrg.org">ICRG - International Center for Responsible Gaming</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
